18 February - 19 February 2020

Applied late-stage functionalisation: where chemistry meets biology

Organised by:

SCI’s Fine Chemicals Group and RSC’s Biological and Medicinal Chemistry Sector

Manchester, UK

Register for this event

Prices start from £230.00

Synopsis
The last decade has seen the rapid development of Late-stage functionalisation as a powerful method for enabling rapid SAR generation from a lead structure and allowing access to complex structures, biological probes and new chemical space where de-novo synthesis is not trivial. Both the inorganic catalyst and biocatalysis fields have seen new advancements over the last few years with the search for more efficient, selective, functional group tolerant, predictable methodology and new late stage transformations still a key focus. Not only are LSF methods of use in rapid SAR generation but are also finding great utility throughout the pharmaceutical industry, from metabolic identification to scale-up processes. The purpose of this meeting is to highlight some of the hot and emerging developments in the inorganic catalysis and biocatalysis arenas and both the academic and application of Late-stage functionalisation methodologies.
Attendees
This meeting is aimed at industrial and academic members of the scientific community working in pharmaceuticals, medicinal chemistry, biochemistry, biotechnology, chemical biology or broadly interested in synthesis, catalysis and enzymatic reactions. The programme will be of interest to academics, postgraduates, undergraduates and early to late career industrialists across CRO’s, SME’s and large organisations.
Programme
The full programme will be announced in due course.
Confirmed Speakers
  • Prof John Hartwig, University of California, Berkeley, USA
  • Prof Tobias Ritter, University of Harvard, USA & Max Planck Institute, Germany
  • Prof Uwe Bornscheuer, University of Greifswald, Germany
  • Prof Jared Lewis, University of Indiana, Bloomington, USA
  • Dr Julia Shanu-Wilson, Hypha, UK
  • Dr Martin Hayes, AstraZeneca, Sweden
  • Dr Cara Brocklehurst, Novartis, Switzerland

Venue and Contact

University of Manchester

Barnes Wallis Building
Sackville Street Campus
Manchester
M1 7JA

Conference Team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org


Fees

Early bird fees before Friday 13 December 2019

£230 SCI Member
£80 SCI Student Member
£300 Non-Member

Standard fees after Friday 13 December 2019

£360 SCI Member
£100 SCI Student Member
£430 Non-Member

SCI Platinum Corporate Members receive 25% off the above rates


Become an SCI Member and save on this and future events

See Membership Options

Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations


Booking Process

Read our event booking terms and conditions


Partners

Exhibition and Sponsorship

An exhibition will take place alongside the conference for companies and related organisations who may wish to exhibit. Please email conferences@soci.org for further information and prices. Spaces are limited and will be allocated on a first-come, first-served basis.


Call for papers

Contributions are invited from those working in all areas of composites manufacture, research, development, commercialization and use.

There are three options:

  • Oral paper (20 minutes)
  • Flash poster presentation (5 slides, 5 minutes)
  • Poster

An abstract of maximum one A4 page or 300 words indicating title, authors and preference for presentation option (Oral, Flash or Poster) should be sent to conferences@soci.org by Friday 13 December 2019 with the subject line "LSF 2020 – abstract submission". Oral presentation slots are inevitably limited and will be allocated to achieve a balanced programme. Topics may be results, reviews or plans and may have already been presented elsewhere. An abstract template can be downloaded here. Prizes will be awarded for the best poster.


Organising Committee
  • Brian Cox, University of Sussex
  • Chris Davis, SCI / Vertex
  • Liz Jones, SCI / Syngenta
  • Igor Larrosa, SCI / University of Manchester
  • Martin Lowe, SCI / UCB
  • Tom Pesnot, SCI / Concept life sciences
  • Nick Turner, University of Manchester
  • Francis Wilson, Summit Therapeutics